Update to post below: Our vaginal mesh lawsuits have settled and we are no longer able to take these cases. If you have any questions regarding the settlement, please call 1-888-377-8900 (toll free) to talk to an attorney.
Women have won millions from vaginal mesh manufacturers, including $3.6 millions for a woman injured by a C.R Bard Avaulta transvaginal mesh product and $11 million for a woman injured by an Ethicon ProLift mesh product. Ethicon is owned by Johnson & Johnson.
Our clients have suffered so much pain. It is a privilege to help women hold C.R. Bard, Johnson & Johnson and others accountable.
The $3.6 million verdict against C.R Bard happened in July of last year. Yesterday, the first of four Bard mesh bellwether trials began. The trials are taking place in the U.S. District Court in the Southern District of West Virginia. At this time, the Court plans to try the cases consecutively in the following order:
Cisson, et al. v. C. R. Bard, Inc. 2:11-cv-00195
Queen, et al. v. C. R. Bard, Inc. 2:11-cv-00012
Rizzo, et al. v. C. R. Bard, Inc. 2:10-cv-01224
Jones v. C. R. Bard, Inc. 2:11-cv-00114
The lawsuits claim that the pelvic mesh products polypropylene, which is not compatible with human tissue and promotes a negative reaction. This negative response promotes inflammation of the pelvic tissue and can contribute to the formation of severe adverse reactions to the mesh. Hyper-inflammatory responses can cause chronic pain and fibrotic reaction. Nerves, tissue and organs can be destroyed or seriously damage. The vagina, bladder and rectum are at greatest risk of damage.